| Literature DB >> 15364068 |
Valerie Olivier1, Nathalie Faucheux, Pierre Hardouin.
Abstract
As life expectancy increases, so does the need to treat large bone defects. New biomaterials combined with osteogenic cells are now being developed as an alternative to autogenous bone grafts. The goal is to make the stem cells adhere to the scaffold, and then grow to differentiate into functional osteogenic cells and organize into healthy bone as the scaffold degrades. Decisive improvements have been made in the fields of stem cell biology, 3-D scaffold fabrication and tissue engineering, but the ideal bone substitute that fulfils all functional and safety requirements has yet to be developed.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15364068 DOI: 10.1016/S1359-6446(04)03222-2
Source DB: PubMed Journal: Drug Discov Today ISSN: 1359-6446 Impact factor: 7.851